Cleveland Eye Clinic Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2020
NCT04380857
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Thomas Chester, OD | William Wiley, MD